Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 47Unknown 21Recruiting 15Active not recruiting 8Terminated 4Not yet recruiting 4Enrolling by invitation 3Withdrawn 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Neoplasms 73Breast Neoplasms 70Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 25Stomach Neoplasms 20Carcinoma, Hepatocellular 20Uterine Cervical Neoplasms 19Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Brain Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 11Esophageal Neoplasms 10Diabetes Mellitus 10Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Sarcoma 8Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Multiple Myeloma 8Esophageal Squamous Cell Carcinoma 8Disease 8

Interventions

somapacitan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Diabetes Mellitus, Type 2 × Clear all
NCT05785780 2026-05-29

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Rutgers, The State University of New Jersey

Phase NA Enrolling by invitation
30 enrolled

Diabetes Mellitus, Type 2

NCT06709040 2026-04-06

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Novo Nordisk A/S

Enrolling by invitation
500 enrolled
Endocrine

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

NCT01511393 2023-06-13

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Novo Nordisk A/S

Enrolling by invitation
6,750 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 2, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡